New Brain Cancer Vaccine Shows Potential Benefits for Patients

Every year, glioblastoma, the most lethal type of brain cancer, is diagnosed in approximately 15,000 individuals in the United States. With a grim survival rate of only 7% beyond five years, the prognosis for these patients has long been bleak. However, hope is on the horizon as researchers are working on a new vaccine that may extend the lives of those affected. NBC’s Anne Thompson shares the latest developments on this promising treatment in her report for TODAY.